Reduction of Diabetic Macular Edema by Oral Administration of the Kinase Inhibitor PKC412.
Campochiaro, P.A., The C99-PKC412-003 Study Group
Invest. Ophthalmol. Vis. Sci. 2004, 45:922-931.
2004